72 related articles for article (PubMed ID: 31734282)
1. Production of fast-dissolving low-density powders for improved lung deposition by spray drying of a nanosuspension.
Šimková K; Joost B; Imanidis G
Eur J Pharm Biopharm; 2020 Jan; 146():19-31. PubMed ID: 31734282
[TBL] [Abstract][Full Text] [Related]
2. Lipid-based particle engineering via spray-drying for targeted delivery of antibiotics to the lung.
Corzo C; Crvenjak D; Sotirov K; Afonso Urich J; Öhlinger K; Meindl C; Lochmann D; Reyer S; Fröhlich E; Zimmer A; Salar-Behzadi S
Int J Pharm; 2023 Jul; 642():123201. PubMed ID: 37406948
[TBL] [Abstract][Full Text] [Related]
3. Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers.
Acosta MF; Abrahamson MD; Encinas-Basurto D; Fineman JR; Black SM; Mansour HM
AAPS J; 2020 Nov; 23(1):2. PubMed ID: 33200330
[TBL] [Abstract][Full Text] [Related]
4. Process development of inhalation powders containing simvastatin loaded liposomes using spray drying technology.
Barbălată CI; Porfire AS; Ambrus R; Mukhtar M; Farkas Á; Tomuță I
J Liposome Res; 2024 Sep; 34(3):421-434. PubMed ID: 37998080
[TBL] [Abstract][Full Text] [Related]
5. Inhalation powder development without carrier: How to engineer ultra-flying microparticles?
Lechanteur A; Gresse E; Orozco L; Plougonven E; Léonard A; Vandewalle N; Lumay G; Evrard B
Eur J Pharm Biopharm; 2023 Oct; 191():26-35. PubMed ID: 37595762
[TBL] [Abstract][Full Text] [Related]
6. The effects of excipients and particle engineering on the biophysical stability and aerosol performance of parathyroid hormone (1-34) prepared as a dry powder for inhalation.
Shoyele SA; Sivadas N; Cryan SA
AAPS PharmSciTech; 2011 Mar; 12(1):304-11. PubMed ID: 21271316
[TBL] [Abstract][Full Text] [Related]
7. Design and Solidification of Fast-Releasing Clofazimine Nanoparticles for Treatment of Cryptosporidiosis.
Zhang Y; Feng J; McManus SA; Lu HD; Ristroph KD; Cho EJ; Dobrijevic EL; Chan HK; Prud'homme RK
Mol Pharm; 2017 Oct; 14(10):3480-3488. PubMed ID: 28929769
[TBL] [Abstract][Full Text] [Related]
8. Controlled Pulmonary Delivery of Carrier-Free Budesonide Dry Powder by Atomic Layer Deposition.
La Zara D; Sun F; Zhang F; Franek F; Balogh Sivars K; Horndahl J; Bates S; Brännström M; Ewing P; Quayle MJ; Petersson G; Folestad S; van Ommen JR
ACS Nano; 2021 Apr; 15(4):6684-6698. PubMed ID: 33769805
[TBL] [Abstract][Full Text] [Related]
9. Microparticle encapsulation of a tuberculosis subunit vaccine candidate containing a nanoemulsion adjuvant via spray drying.
Gomez M; Archer M; Barona D; Wang H; Ordoubadi M; Bin Karim S; Carrigy NB; Wang Z; McCollum J; Press C; Gerhardt A; Fox CB; Kramer RM; Vehring R
Eur J Pharm Biopharm; 2021 Jun; 163():23-37. PubMed ID: 33753213
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effects of storage conditions on spray-dried siRNA-LNPs before and after subsequent drying.
Zimmermann CM; Deßloch L; Jürgens DC; Luciani P; Merkel OM
Eur J Pharm Biopharm; 2023 Dec; 193():218-226. PubMed ID: 37956785
[TBL] [Abstract][Full Text] [Related]
11. Modern trends in the formulation of microparticles for lung delivery using porogens: methods, principles and examples.
Peštálová A; Gajdziok J
Pharm Dev Technol; 2024 Jun; 29(5):504-516. PubMed ID: 38712608
[TBL] [Abstract][Full Text] [Related]
12. Inhalable dry powder product (DPP) of mRNA lipid nanoparticles (LNPs) for pulmonary delivery.
Sarode A; Patel P; Vargas-Montoya N; Allawzi A; Zhilin-Roth A; Karmakar S; Boeglin L; Deng H; Karve S; DeRosa F
Drug Deliv Transl Res; 2024 Feb; 14(2):360-372. PubMed ID: 37526881
[TBL] [Abstract][Full Text] [Related]
13. Poly(malic acid)-budesonide nanoconjugates embedded in microparticles for lung administration.
Tessier B; Moine L; Peramo A; Tsapis N; Fattal E
Drug Deliv Transl Res; 2024 Aug; 14(8):2062-2078. PubMed ID: 38517568
[TBL] [Abstract][Full Text] [Related]
14. Raman characterization and chemical imaging of biocolloidal self-assemblies, drug delivery systems, and pulmonary inhalation aerosols: a review.
Mansour HM; Hickey AJ
AAPS PharmSciTech; 2007 Nov; 8(4):E99. PubMed ID: 18181559
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration.
El-Gendy N; Berkland C
Pharm Res; 2009 Jul; 26(7):1752-63. PubMed ID: 19415471
[TBL] [Abstract][Full Text] [Related]
16. Rapid Room-Temperature Aerosol Dehydration Versus Spray Drying: A Novel Paradigm in Biopharmaceutical Drying Technologies.
Poozesh S; Mezhericher M; Pan Z; Chaudhary U; Manikwar P; Stone HA
J Pharm Sci; 2024 Apr; 113(4):974-981. PubMed ID: 37802368
[TBL] [Abstract][Full Text] [Related]
17. High-loading cannabidiol powders for inhalation.
Tai W; Yau GTY; Arnold JC; Chan HK; Kwok PCL
Int J Pharm; 2024 Jun; 660():124370. PubMed ID: 38906498
[TBL] [Abstract][Full Text] [Related]
18. Formulation and Scale-Up of Fast-Dissolving Lumefantrine Nanoparticles for Oral Malaria Therapy.
Armstrong M; Wang L; Ristroph K; Tian C; Yang J; Ma L; Panmai S; Zhang D; Nagapudi K; Prud'homme RK
J Pharm Sci; 2023 Aug; 112(8):2267-2275. PubMed ID: 37030438
[TBL] [Abstract][Full Text] [Related]
19. Pure insulin nanoparticle agglomerates for pulmonary delivery.
Bailey MM; Gorman EM; Munson EJ; Berkland C
Langmuir; 2008 Dec; 24(23):13614-20. PubMed ID: 18959432
[TBL] [Abstract][Full Text] [Related]
20. Holistic Study Design Following Quality by Design Approach for Fabrication of Hybrid Polymeric Nanoparticulate Based Dry Powders as Carriers for Ciprofloxacin.
Ambrus R; Csóka I; Fenyes E; Orosz L; Sarkadi ÁN; Burián K; Kókai D; Mukhtar M
J Pharm Sci; 2024 Jul; 113(7):1946-1959. PubMed ID: 38643899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
